Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Anna L, Greenshields"'
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
The single antigen bead (SAB) assay is the most used test for the identification of HLA specific antibodies pre- and post-transplant. Nevertheless, detection of spurious reactivities remains a recognized assay limitation. In addition, the presence of
Externí odkaz:
https://doaj.org/article/fe27d835246e4b588449163f82edad52
Autor:
Dulat Bekbolsynov, Beata Mierzejewska, Jadwiga Borucka, Robert S. Liwski, Anna L. Greenshields, Joshua Breidenbach, Bradley Gehring, Shravan Leonard-Murali, Sadik A. Khuder, Michael Rees, Robert C. Green, Stanislaw M. Stepkowski
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
We evaluated the impact of human leukocyte antigen (HLA) disparity (immunogenicity; IM) on long-term kidney allograft survival. The IM was quantified based on physicochemical properties of the polymorphic linear donor/recipient HLA amino acids (the C
Externí odkaz:
https://doaj.org/article/1242a400cb9446fb9ee95c2daa76fe19
Autor:
Fabrice Le Boeuf, Simon Gebremeskel, Nichole McMullen, Han He, Anna L. Greenshields, David W. Hoskin, John C. Bell, Brent Johnston, Chungen Pan, Roy Duncan
Publikováno v:
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 80-89 (2017)
The reovirus fusion-associated small transmembrane (FAST) proteins are the smallest known viral fusogens (∼100–150 amino acids) and efficiently induce cell-cell fusion and syncytium formation in multiple cell types. Syncytium formation enhances c
Externí odkaz:
https://doaj.org/article/3cd936949ec64f11bd4b289f8ff2b5b9
The single antigen bead (SAB) assay is the most used test for the identification of HLA specific antibodies pre- and post-transplant. Nevertheless, detection of spurious reactivities remains a recognized assay limitation. In addition, the presence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d70b4809b0e15bb48b4e2173480bfc7
https://hdl.handle.net/11541.2/32305
https://hdl.handle.net/11541.2/32305
Autor:
Bruce E. Holbein, Wasundara Fernando, David W. Hoskin, Melanie R. Power Coombs, Anna L. Greenshields
Publikováno v:
BioMetals. 32:909-921
Breast cancer is a leading cause of cancer-related death in women; however, chemotherapy of breast cancer is often hindered by dose-limiting toxicities, demonstrating the need for less toxic approaches to treatment. Since the rapid growth and metabol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee032d8275137122188015e44226a0bd
https://doi.org/10.1007/s10534-019-00222-3
https://doi.org/10.1007/s10534-019-00222-3
Autor:
Anna L. Greenshields, Robert S. Liwski
Publikováno v:
Human Immunology. 80:478-486
Accurate identification of HLA antibodies using the single antigen bead (SAB) assay is critical for assessment of pre/post-transplant immunological risk and successful virtual crossmatching. Unfortunately, high titer HLA antibodies can be missed or u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b52fe123b1e44fda628e1a27ee581ec
https://doi.org/10.1016/j.humimm.2019.04.019
https://doi.org/10.1016/j.humimm.2019.04.019
Autor:
Wasundara Fernando, David W. Hoskin, Allison F. Knickle, H.P. Vasantha Rupasinghe, Anna L. Greenshields
Publikováno v:
Food and Chemical Toxicology. 118:154-167
Myricetin is a dietary phytochemical with anticancer activity; however, the effect of myricetin on breast cancer cells remains unclear. Here, we show that myricetin inhibited the growth of triple-negative breast cancer (TNBC) cells but was less inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf88cbf1b5cdc4bda316810fcbc59937
https://doi.org/10.1016/j.fct.2018.05.005
https://doi.org/10.1016/j.fct.2018.05.005
Autor:
Howard M. Gebel, Jorge Neumann, Robert S. Liwski, Cathi Murphey, Anna L. Greenshields, David M. Conrad, Robert A. Bray
Publikováno v:
Human Immunology. 79:28-38
The flow cytometric crossmatch (FCXM) assay, which detects the presence of donor specific HLA antibodies in patient sera, is a cornerstone of HLA compatibility testing. Since relatively long FCXM assay turnaround times may contribute to transplant de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80895887611772034b100bebd82e84b6
https://doi.org/10.1016/j.humimm.2017.10.020
https://doi.org/10.1016/j.humimm.2017.10.020
Autor:
Roy Duncan, Han He, David W. Hoskin, John C. Bell, Brent Johnston, Nichole McMullen, Simon Gebremeskel, Anna L. Greenshields, Fabrice Le Boeuf, Chungen Pan
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 80-89 (2017)
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 80-89 (2017)
The reovirus fusion-associated small transmembrane (FAST) proteins are the smallest known viral fusogens (∼100–150 amino acids) and efficiently induce cell-cell fusion and syncytium formation in multiple cell types. Syncytium formation enhances c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a98ebf878f5f5da31d53558b5f409a
http://europepmc.org/articles/PMC5562180
http://europepmc.org/articles/PMC5562180
Publikováno v:
Human Immunology. 78:489-499
The LABScreen single antigen bead assay (SAB) is a method widely used for the identification and monitoring of human leukocyte antigen (HLA) antibodies in patients pre-and post-transplant. While accurate testing of patient samples is key for optimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8324873a7ca50decd2cf3897def04e2
https://doi.org/10.1016/j.humimm.2017.05.001
https://doi.org/10.1016/j.humimm.2017.05.001